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Several factors contribute to the high mortality attributed to severe infections in resource-limited settings. While
improvements in survival and processes of care have been made in high-income settings among patients with
severe conditions, such as sepsis, guidelines necessary for achieving these improvements may lack applicability or
have not been tested in resource-limited settings. The World Health Organization’s recent publication of the
Integrated Management of Adolescent and Adult Illness District Clinician Manual provides details on how to
optimize management of severely ill, hospitalized patients in such settings, including specific guidance on the
management of patients with septic shock and respiratory failure without shock. This manuscript provides the
context, process and underpinnings of these sepsis guidelines. In light of the current deficits in care and the
limitations associated with these guidelines, the authors propose implementing these standardized best practice
guidelines while using them as a foundation for sepsis research undertaken in, and directly relevant to, resource-
limited settings.
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To provide guidance on a comprehensive approach to the
management of children and adult patients with common
diseases and conditions in resource-limited settings, the
World Health Organization (WHO) has coordinated the
development of a set of integrated management tools.
These tools, comprised of guidelines and health worker
training modules, include the Integrated Management of
Childhood Illness, the Integrated Management of Preg-
nancy and Childbirth, and the Integrated Management of
Adolescent and Adult Illness (IMAI). Many of these tools
have been widely disseminated globally [1]. In July 2011,
the WHO approved the publication of the most recent
addition to the integrated management series, the IMAI* Correspondence: sjacob2@uw.edu
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reproduction in any medium, provided the orDistrict Clinician Manual (DCM). This document, just
released on-line and in print, is a two-volume publica-
tion providing guidance on the care of hospitalized
adult patients in district hospitals from resource-limited
settings [2].
In resource-limited settings, management of severely
ill patients is particularly challenging due to a difficult
balance between a high caseload of patients and the cor-
respondingly low supply of necessary medical equipment
and human resources [3,4]. Public health crises such as
the 2009 H1N1 influenza pandemic have reinforced con-
cerns about the potential for a rapid overwhelming of
the global health system’s capacity to manage patients
with severe acute illness, particularly in settings with
limited resources [5]. To address this challenge, the
DCM emphasizes a practical and systematic approach to
triage and management of all patients presenting to the
hospital in resource-limited settings with an acute ill-
ness, including those who are critically ill.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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populations in low and middle income countries and
cause correspondingly high mortality rates [6,7]. Regard-
less of the etiology, one of the most common pathways
contributing to this mortality is the ‘sepsis syndrome’,
defined by the presence of both infection and a systemic
inflammatory response. Further along the severity spectrum
of this syndrome, severe sepsis and septic shock can occur
with increasing lethality resulting from progression to
end-organ damage and refractory hypotension [8]. While
it is poorly quantified, the global burden of sepsis is un-
doubtedly massive. Extrapolating from North American
data, some 15 to 20 million cases of severe sepsis among
adults occur worldwide each year, half of which may be
fatal [9]. Available data on sepsis management of adults in
resource-limited settings suggest that this high mortality
is associated with ineffective management including de-
layed and improper empiric antimicrobial therapy as well
as sub-optimal fluid resuscitation [10,11]. Thus, attention
to reducing the mortality from sepsis by focusing on im-
proved management in these settings is urgently needed.
Given the importance of this condition, in 2009 the
WHO convened an international group of experts to re-
view the current management of sepsis and to identify
an evidence-based strategy and approach for sepsis man-
agement in resource-limited settings. These guidelines
were subsequently included in the IMAI DCM as a
framework for the management of severe acute illness
in adults. The purpose of this article is to delineate the
barriers to optimal sepsis management in resource-
limited settings, describe the approach used to develop
the IMAI DCM sepsis guidelines and their inherent lim-
itations, identify the knowledge gaps and highlight key
questions that must be answered to further inform and
refine best practice for the management of sepsis in
these settings.
Current standard of care of sepsis in high-resource
settings
Studies conducted in high-income countries have sug-
gested a benefit from early sepsis identification coupled
with targeted interventions in the management of pa-
tients with severe sepsis. These interventions include
rapid administration of appropriate antimicrobial therapy,
additional source control of infection as needed, and
optimization of tissue perfusion using fluids, vasopres-
sors and inotropes, and red blood cell transfusions.
These initial actions are accompanied by support of
failing organs and appropriate efforts to minimize com-
plications. Protocol-driven strategies are the basis for
the best practice guidelines for sepsis care promulgated
by the International Surviving Sepsis Campaign [12].
Several independent, multi-site studies from middle
and high income countries have demonstrated improvedsurvival in parallel with improvements in compliance with
aggregate best practice guidance (‘sepsis bundles’) [12-22].
Importantly, the results of studies re-evaluating the effi-
cacy of certain sepsis bundle components (for example,
activated protein C, tight glucose control and low-dose
steroids) has led to revision, and sometimes removal,
of these components in more recent iterations of the
guidelines [23]. Thus, in an effort to independently evalu-
ate goal-directed resuscitation in adults with septic shock,
three parallel randomized-controlled multicenter trials
in Australia, the USA and the UK are underway [24-26].
Applicability of existing sepsis guidelines to resource-
limited settings
While there is some evidence to support the feasibility
of implementing modified sepsis management guidelines
in resource-limited settings [27], substantial health sys-
tem and resource challenges impede the translation of
current best practice guidelines in these environments
[28-31]. For example, variable access and long distances
to hospitals contribute to severely ill patients presenting
to the health system. In addition, triage capacity is often
absent in district hospitals, leading to further delays in
recognizing ill patients and initiating treatment. Once
recognized, a lack of effective antimicrobials, oxygen and
intravenous fluids may further impair provision of opti-
mal sepsis care. Moreover, human resources are often
scarce with respect to both quantity and expertise, thus
precluding the labor-intensive iterative approach that
characterizes sepsis management in high resource settings.
Identifying which should be the priority interventions
for sepsis management in a resource-limited setting is a
further challenge. While evidence exists for the benefit
of prompt and appropriate antimicrobial therapy, an-
swering questions regarding the utility of other therapies
commonly available in high-resource settings is difficult.
For example, are intravenous fluid boluses safe in the
absence of close patient monitoring and respiratory sup-
port equipment? Are central venous catheters beneficial
for guiding volume resuscitation in a resource-limited
setting when weighed against the attendant risks of
mechanical complications and infection? Given global
efforts to improve oxygen monitoring capacity and sup-
ply, what level of oxygen should be targeted in septic
patients? Furthermore, it is not known if (or which) iso-
lated interventions in sepsis, unbundled from the packages
of sepsis care that have been adopted in high resource hos-
pitals, may still result in net benefit.
The etiologies of sepsis in many resource-limited
environments differ from high resource settings or have
not been well described. Bacteraemia studies implicate
a wide range of pathogens [10,32-34]. Many other or-
ganisms including Plasmodium falciparum, dengue
virus, influenza, Mycobacterium tuberculosis, Cryptococcus
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ical illness that cannot be easily distinguished from typical
bacterial sepsis [10,35-39]. In addition, immune suppres-
sion from HIV is an important risk factor for adult sepsis
in places where HIV prevalence is high [10]. Thus, clinical
trials of sepsis therapies conducted in high-resource set-
tings and targeting mostly bacterial infection may not be
generalizable to resource-limited settings. This issue is
further compounded by the dearth of diagnostic cap-
acity to identify the specific etiologies of sepsis and to
determine antimicrobial susceptibility in most district
hospitals. Consequently, there is little empirically-derived
local or regional data to guide hospital procurement and
clinician selection of appropriate antimicrobial treatment.
Finally, populations in resource-limited settings are likely
to differ from those in high-resource settings in a variety
of ways. Nutritional status, co-morbidities, health seeking
behaviors, access to health care, and use of over-the-counter
and sub-standard or counterfeit antimicrobials may all
influence the mode of presentation that can impact clin-
ical outcome. Thus, management strategies developed
in high-resource populations may not be directly applic-
able in resource-limited populations.
An excellent example of the risk of extrapolating prin-
ciples of sepsis care across settings was demonstrated by
the recent FEAST trial [40]. This large trial involving
more than 3,000 African children with severe acute in-
fections showed that children receiving fluid boluses had
a higher mortality than children receiving no fluid bolus.
This unexpected finding, which arguably may be more
generalizable to adults in the same setting than findings
from studies performed in developed countries, suggests
that validation studies are required to establish the bene-
fit of the IMAI approach which is largely based on lower
level evidence. Furthermore, mortality among all patients
enrolled in the FEAST trial was strikingly lower (9.4%)
than in severely ill children enrolled in previous studies
from similar settings (28.2%) [41]. This effect may be at-
tributable to targeted training of all health staff on triage
and monitoring prior to commencement of the study and
supports the importance of emergency care training of
health workers.
A sepsis management pathway in resource-limited
settings
Starting in April 2009, a working group was convened
by the WHO to develop sepsis management guidelines
in resource-limited settings. The group comprised 18
international experts from five continents trained in
internal medicine, emergency medicine, anesthetics, crit-
ical care, infectious disease and pulmonology. Three face-
to-face meetings (one co-incident with the IMAI DCM
pulmonary and emergency expert groups meeting), evi-
dence review and numerous email consultations wereheld. Development of the guidelines occurred by con-
sensus and recommendations were not necessarily re-
stricted by the lack of a high quality evidence base.
These efforts eventually dovetailed with the IMAI DCM
development process (in development since 2006) and
in November 2009, the sepsis guidelines were adapted
for management of severely ill patients during the
H1N1 influenza pandemic [42]. In July 2011, prior to its
final approval for publication, the WHO held a three-
day external review of the IMAI DCM which includes
the sepsis guidelines for resource-limited settings.
The guidelines take into consideration potential re-
source constraints, acknowledging that much of the world
does not have access to advanced diagnostics or resuscita-
tive techniques. They provide instruction on sepsis man-
agement in resource-limited environments throughout a
patient’s hospitalization course with emphasis on the first
2 hours (Figure 1a), 2 to 6 hours (Figure 1b), 6 to 24 hours
(Figure 1c) and post-resuscitation periods (Figure 1d) [2].
The guidelines call for the early recognition of two of the
most important indicators of organ dysfunction in sepsis:
hypotension and acute respiratory distress. Key manage-
ment principles reiterated through the guidelines include
early recognition, treating infection early and broadly
while establishing source control and fixing physiologic
aberrations by optimizing tissue perfusion with judicious
fluids and oxygen. In addition, the guidelines emphasize
regular and frequent monitoring of the patient's response
to treatment and a plan for appropriate action based on
changes in clinical status. In light of the risk of volume
overloading patients with possible acute lung injury/acute
respiratory distress syndrome, the guidelines specify more
conservative fluids for such patients (1 ml/kg/hour intra-
venously or orally) and other appropriate modifications
in the resuscitation strategy. Further guidance on the
management of conditions which may deviate from
these guidelines is provided in the DCM, including a
more conservative fluid management strategy for dengue;
careful attention to possible development of fluid overload/
pulmonary edema in severe malaria; specific antimicrobial
recommendations for malaria, tuberculosis, maternal
sepsis-related conditions (for example, amnionitis, post-
partum sepsis and septic abortion) and certain viral
hemorrhagic fevers (such as Lassa fever).
Most importantly, these guidelines do not exist within
a vacuum. They are situated within a larger context of
expedited assessment, triage and immediate intervention,
using algorithms that rapidly differentiate life threatening
emergency conditions from those that require less urgent
care. Thus, all patients are similarly triaged by assessing
whether they exhibit emergency signs related to the
airway and breathing (obstruction, central cyanosis, se-
vere respiratory distress), circulation (weak or fast
pulse, capillary refill longer than three seconds, heavy
Figure 1 Guidelines for the management of septic shock and severe respiratory distress without shock in resource-limited settings. (a)
Algorithm for the first 2 hours of hospitalization. (b) Algorithm for hours 2 to 6 after hospitalization. (c) Algorithm for hours 6 to 24 after
hospitalization. (d) Algorithm for the post-resuscitation period. (Permission granted by the World Health Organization for reproducing the
contents of this figure from the IMAI District Clinician Manual [2].)
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ness or convulsions or pain from a life-threatening
cause [43]. The sepsis management algorithm is only trig-
gered once underlying infection is suspected and other
causes of circulatory impairment have been excluded.
To avoid inappropriate guideline implementation, em-
phasis is placed on supporting clinical reasoning and use of
differential diagnosis tables. Ultimately, patients are treated
for the most likely and urgent disease syndromes without
premature exclusion of alternative diagnoses, using
methods and resources available even in resource-limited
settings.
Successful sepsis algorithm implementation depends,
above all, on improving health worker capacity to man-
age severely ill patients through effective training to use
the algorithm as well as constant revision through new
research. Accordingly, a district hospital training pro-
gram based on the DCM to improve the capacity for tri-
age and management of severe acute illness focused on
septic shock and respiratory distress has been piloted by
the WHO in Uganda, Malawi, Ethiopia and Rwanda. In
addition to the principles of triage and management, the
training also emphasizes the importance of achieving
clinical management benchmarks using targeted clinical
performance measures based on reasonable standards of
care in resource-limited settings. Also, simplified data
collection instruments that allow bedside clinical and
laboratory documentation are introduced to inform
therapeutic adjustments when necessary and facilitate
long-term quality improvement and clinical research
efforts. A similar training program has already been
shown to reduce mortality in pediatric patients in a
resource-limited setting [44].
Limitations, knowledge gaps and future directions
The proposed sepsis pathway is based on a sound physio-
logical rationale and is derived from the best evidence
currently available pertinent to the care of adults with
sepsis, most of which was developed in high resource
settings. A subsequent independent evidence-based re-
view of sepsis management in resource-limited settings
arrived at very similar recommendations and confirmed
that evidence from resource-limited settings is deplor-
ably scarce [45]. Despite the lack of empirically derived
data in resource-limited settings, we propose that it is
ethically acceptable to provide guidelines to health care
providers that are based on the application of sound
physiological principles and the best available current
evidence. It is also essential, however, that research be
undertaken to evaluate areas of uncertainty in the guide-
lines (for example, determining the safest and most effica-
cious volume of fluid resuscitation for improving sepsis
survival) and to validate the effectiveness of the guidelines’
performance in appropriate settings with modificationof the guidelines based on these findings. This process
of validating and revising guidelines mirrors the ap-
proach used in high resource settings by the Surviving
Sepsis Campaign [46]. Given the unique challenges of
infrastructure and human capacity limitations and the
substantial knowledge gaps specific to resource-limited
settings, key issues for further investigation include:
1. Evaluating the efficacy and effectiveness of training
in the proposed management pathway for improving
patient outcomes and health care worker
performance, particularly in patient populations and
settings where invasive monitoring and extensive
laboratory investigations are absent.
2. Improving the recognition and defining the natural
history of sepsis caused by organisms endemic in
developing countries, while refining management of
those clinical syndromes where a pathogen-specific
guideline may be superior. Further clinical research
is necessary to determine where and how the
proposed guidelines can complement existing
disease-specific recommendations and whether
specific components require further evaluation.
3. Through the evaluation of severity scoring systems
and differing clinical definitions, defining groups for
which early intervention may be either particularly
beneficial or futile.
4. Determining the potential benefit of adjunctive
treatments (such as non-invasive ventilation) and
interventions that may augment current care (for
example, the use of oral fluids, the use of ultrasound
to guide amount of fluid resuscitation, the role of
early feeding and micronutrient supplementation
and the training of patient relatives as clinical care
attendants).
5. Conducting relative cost-benefit analyses addressing
supply issues and resource utilization for basic
treatments, such as oxygen, intravenous fluids and
antimicrobials can aid health facilities in determining
how to prioritize resources required for sepsis
management.
6. Tailoring treatment more effectively by enhancing
on-site diagnosis, through either improved basic
microbiology services, expanded sentinel
surveillance microbiologic laboratory sites or the use
of novel rapid diagnostic tests comprising assays
which can identify sepsis etiology and/or provide
prognostic information at the point of care.
Conclusion
Current evidence suggests that the mortality and morbid-
ity of severe sepsis can be improved by effective clinical
interventions applied in a timely and systematic manner.
In resource-limited settings where the burden of disease
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barriers to the adoption of such practices. The essential
elements of care of critically ill patients in resource-
limited settings are a triage system that identifies crit-
ical illness quickly, appropriate protocols for managing
common medical emergencies, the availability of requisite
interventions, targeted training of providers in critical care
principles, and a data collection and quality management
system to monitor implementation and impact. This
sepsis management pathway for resource-limited set-
tings, a subset of the larger severe illness recognition
and management algorithms within the IMAI District
Clinician Manual, adheres to these principles and pro-
vides an essential first step in improving outcomes. It
should be feasible to design and implement a package
comprising these elements adapted for any setting
but in order to ensure that such guidelines fulfill
their potential for saving lives, a robust global effort
championing training and research in the manage-
ment of acute severe illnesses, such as sepsis, in
resource-limited settings is essential.
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